Long Term Safety and Efficacy Study of SAR442168 in Participants With Relapsing Multiple Sclerosis
Condition: Relapsing Multiple Sclerosis Intervention: Drug: SAR442168 Sponsor: Sanofi Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials